Clinical Trial

A Multilevel Intervention for Low Back Pain Management in Primary Care

Study acronym: PRIME Back
Recruiting
View on ClinicalTrials.gov →
Summary
Low back pain is the leading cause of disability worldwide and one of the main reasons for consulting in primary care. This project aims to improve the management of people with low back pain in primary care through an innovative intervention developed in collaboration with general practitioners, physiotherapists, and occupational therapists. The main objective is to test the effectiveness of a multilevel intervention designed to improve the care pathway for individuals with low back pain consulting their general practitioner. The intervention supports healthcare professionals in adopting practices based on current guidelines, promotes patient education, and offers an interprofessional care pathway tailored to each person's needs and profile. The study will include over 100 general practitioners in French-speaking Switzerland, randomly assigned to either the intervention group or the control group (usual care). Around 500 patients will be followed according to their doctor's approach. Their progress will be monitored over 12 months using questionnaires and administrative data. This project addresses an urgent need to improve the care pathway in primary care. It will rigorously assess the effectiveness of this new care approach and explore the barriers and facilitators to its integration into daily practice, taking into account the experiences of both healthcare professionals and the people concerned.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-15.
Status change: Not Yet Recruiting → Recruiting 2026-02-10
Trial Details
NCT Number NCT07137065
Lead Sponsor Guillaume Christe
Collaborators: Haute Ecole de Santé Vaud (HESAV), Lausanne, Switzerland, University of Geneva, Switzerland
Conditions Low Back Pain
Enrollment 500 participants
Start Date 2026-02-05
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-12